Inhibiting drug efflux transporters improves efficacy of ALS therapeutics

OBJECTIVE: Research identified promising therapeutics in cell models of Amyotrophic Lateral Sclerosis (ALS), but there is limited progress translating effective treatments to animal models and patients, and ALS remains a disease with no effective treatment. One explanation stems from an acquired pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Jablonski, Michael R, Markandaiah, Shashirekha S, Jacob, Dena, Meng, Ni J, Li, Ke, Gennaro, Victoria, Lepore, Angelo C, Trotti, Davide, Pasinelli, Piera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284125/
https://www.ncbi.nlm.nih.gov/pubmed/25574474
http://dx.doi.org/10.1002/acn3.141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284125/
https://www.ncbi.nlm.nih.gov/pubmed/25574474
http://dx.doi.org/10.1002/acn3.141

Ejemplares similares